Most cited papers from Meridien Research

Meridien Research

What are the most cited papers from Meridien Research?

The most cited paper from Meridien Research is "Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients" (Robert Gottlieb et al., 2021), with 1,288 citations. Next come "All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study" (694) and "Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 Protease" (529).

Published TypeFieldAccessCitations

Showing 50 of 62 papers. Every paper with more than 26 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients Robert Gottlieb et al. · New England Journal of Medicine Open access	22 Dec 2021	1,288
2	All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study David R. Nelson et al. · Hepatology Open access	23 Jan 2015	694
3	Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 Protease John W. Erickson, David J. Neidhart, John H. VanDrie et al. · Science Open access	3 Aug 1990	529
4	A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial Scott Haden Kollins, Denton J. DeLoss, Elena Cañadas et al. · The Lancet Digital Health Open access	24 Feb 2020	406
5	Green Tea Catechin Consumption Enhances Exercise-Induced Abdominal Fat Loss in Overweight and Obese Adults Kevin Carl Maki, Matthew S. Reeves, Mildred V. Farmer et al. · Journal of Nutrition Open access	12 Dec 2008	241
6	Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline Pudugramam Murali Doraiswamy et al. · Neurology Open access	12 Jul 2012	231
7	Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes Carol Wysham, Anuj Bhargava, LOUIS B. CHAYKIN et al. · JAMA Open access	3 Jul 2017	222
8	Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women Kevin Carl Maki, Mathew S. Reeves, Mildred V. Farmer et al. · Nutrition Research	Sep 2009	191
9	ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures John H. Van Drie, David Weininger, Yvonne Connolly Martin · Journal of Computer-Aided Molecular Design	Sep 1989	189
10	Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial Eric S. Daar, Edwin DeJesus, Peter Jerome Ruane et al. · The Lancet HIV	18 Jun 2018	182
11	Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial Moshe Laudon, Alan G. Wade, Mildred V. Farmer et al. · Clinical Interventions in Aging Open access	Jun 2014	174
12	Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study P E Keck, Paul J. Orsulak, Andrew J. Cutler et al. · Journal of Affective Disorders	3 Oct 2008	172
13	Cariprazine in Acute Exacerbation of Schizophrenia Suresh Durgam, Andrew J. Cutler, Kaifeng Lu et al. · The Journal of Clinical Psychiatry	21 Dec 2015	168
14	Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus Kevin Carl Maki, Leslie L. Curry, Matthew S. Reeves et al. · Food and Chemical Toxicology	17 May 2008	160
15	Fecundity studies on Acartia tonsa (Copepoda: Calanoida) in standardized culture K. K. Parrish, Donald F. Wilson · Marine Biology	1978	145
16	The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial Sultan Linjawi, Bruce W. Bode, LOUIS B. CHAYKIN et al. · Diabetes Therapy Open access	10 Dec 2016	136
17	Practicality of Intermittent Fasting in Humans and its Effect on Oxidative Stress and Genes Related to Aging and Metabolism Martin P Wegman, Michael H. Guo, Douglas M. Bennion et al. · Rejuvenation Research Open access	29 Dec 2014	136
18	Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder Robert L. Findling, Ann Catherine Childress, Andrew J. Cutler et al. · Journal of the American Academy of Child & Adolescent Psychiatry	7 Mar 2011	122
19	A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder Timothy E. Wilens, Oscar Gary Bukstein, Matthew N. Brams et al. · Journal of the American Academy of Child & Adolescent Psychiatry	3 Dec 2011	115
20	Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study Philip J. Mease et al. · The Journal of Rheumatology Open access	23 Dec 2009	114
21	Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia Andrew J. Cutler, Amir H Kalali, Peter J. Weiden et al. · Journal of Clinical Psychopharmacology	11 Mar 2008	113
22	ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Christopher L. Moertel et al. · Journal of Clinical Oncology Open access	8 Nov 2024	102
23	Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial Guy de Bruyn, Jamshid Saleh, David A. Workman et al. · Vaccine Open access	22 Mar 2016	97
24	Safety Profile of Iloperidone Peter J. Weiden, Andrew J. Cutler, Mihael H. Polymeropoulos et al. · Journal of Clinical Psychopharmacology	11 Mar 2008	94
25	Lower Face André Vieira Braz, Shannon D. Humphrey, Susan H. Weinkle et al. · Plastic & Reconstructive Surgery	6 Oct 2015	85
26	The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis Henry A. Nasrallah, Willie R. Earley, Andrew J. Cutler et al. · BMC Psychiatry Open access	24 Aug 2017	85
27	Teriflunomide added to interferon-β in relapsing multiple sclerosis M. S. Freedman et al. · Neurology	24 May 2012	78
28	Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis Edward Fox, Keith R. Edwards, Gordon Burch et al. · Multiple Sclerosis and Related Disorders	3 Jul 2014	77
29	Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study Andrew J. Cutler, Suresh Durgam, Yao Wang et al. · CNS Spectrums Open access	8 May 2017	71
30	Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1‐5 trials Mark Warren, LOUIS B. CHAYKIN, David E. Trachtenbarg et al. · Diabetes Obesity and Metabolism Open access	24 Apr 2018	69
31	The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure Kevin Carl Maki, Leslie L. Curry, M. C. Carakostas et al. · Food and Chemical Toxicology	17 May 2008	69
32	Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder Charles Merideth, Andrew J. Cutler, Fahua She et al. · International Clinical Psychopharmacology	Nov 2011	68
33	Risk factors associated with increased depressive symptoms among Latinas diagnosed with breast cancer within 5 years of survivorship Claudia X. Aguado Loi, Julie Ann Baldwin, Robert J. McDermott et al. · Psycho-Oncology	3 Sep 2013	66
34	A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder Timothy E. Wilens, Brigitte Robertson, Vanja Sikirica et al. · Journal of the American Academy of Child & Adolescent Psychiatry	15 Sep 2015	63
35	A double‐blind, randomized, placebo‐controlled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis Juan L. Hancke, Shalini Srivastav, Dante Cáceres et al. · Phytotherapy Research Open access	10 Apr 2019	59
36	Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose Kevin Carl Maki, James M. McKenney, Mildred V. Farmer et al. · Nutrition Journal Open access	28 May 2009	59
37	A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram Madhukar H. Trivedi, Andrew J. Cutler, Cynthia Richards et al. · The Journal of Clinical Psychiatry	15 Aug 2013	58
38	Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy Philip Raskin, Cynthia Huffman, Cory C. Toth et al. · Clinical Journal of Pain	25 Jul 2013	53
39	Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results Kathryn Jean Lucas et al. · Digestive and Liver Disease	Feb 2020	51
40	Potato top growth as influenced by temperatures G. R. Benoit, Craig Dean Stanley, Walter J. C. Grant et al. · American Journal of Potato Research	Jul 1983	49
41	Vicryl Mesh in Expander/Implant Breast Reconstruction Daniel F. Haynes, Joshua C. Kreithen · Plastic & Reconstructive Surgery	28 Oct 2014	46
42	Development of a communication intervention to assist hospitalized suddenly speechless patients Carmen S Rodriguez, Meredeth A. Rowe, Brent Koeppel et al. · Technology and Health Care Open access	14 Nov 2012	43
43	Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder Steven R. Pliszka, Timothy E. Wilens, Samantha Bostrom et al. · Journal of Child and Adolescent Psychopharmacology Open access	21 Jul 2017	42
44	Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting Ann Catherine Childress, Scott Haden Kollins, Andrew J. Cutler et al. · Journal of Child and Adolescent Psychopharmacology Open access	16 May 2016	42
45	Extended-Release Quetiapine as Monotherapy for the Treatment of Adults With Acute Mania: A Randomized, Double-Blind, 3-Week Trial Andrew J. Cutler, Catherine J Datto, Arvid Nordenhem et al. · Clinical Therapeutics	Nov 2011	42
46	Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram Paula L. Jacobsen, George G. Nomikos, Wei Zhong et al. · CNS Spectrums Open access	23 Apr 2019	40
47	Community-University Partnerships for Research and Practice: Application of an Interactive and Contextual Model of Collaboration. Heather J. Williamson, Belinda-Rose Young, Nichole Murray et al. · PubMed Open access	2016	40
48	A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder Robert L. Findling, Andrew J. Cutler, Keith E. Saylor et al. · Journal of Child and Adolescent Psychopharmacology	Feb 2013	39
49	Ranitidine for erosive oesophagitis: a double‐blind, placebo‐controlled study Walter M. Roufail, Alphonso A. Belsito, MALCOLM G. ROBINSON et al. · Alimentary Pharmacology & Therapeutics	Oct 1992	39
50	PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury Flora McConnell Hammond, David N. Alexander, Andrew J. Cutler et al. · BMC Neurology Open access	4 Jun 2016	37

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.